Zura Bio Ltd·4

Jun 22, 4:15 PM ET

Thiara Parvinder 4

4 · Zura Bio Ltd · Filed Jun 22, 2026

Research Summary

AI-generated summary of this filing

Updated

Zura Bio (ZURA) Director Thiara Parvinder Receives Award

What Happened

  • Thiara Parvinder, a director of Zura Bio Ltd (ZURA), was granted 51,000 derivative securities (an option award) on June 17, 2026. The grant is reported at $0.00 per share (total reported value $0) and is recorded as an award/acquisition (code A) on the Form 4.

Key Details

  • Transaction date: 2026-06-17; Filing date: 2026-06-22 (appears to be filed 5 days after the transaction).
  • Securities granted: 51,000 derivative securities (option award) reported at $0.00.
  • Shares owned after transaction: Not specified in the filing.
  • Vesting (footnote F1): The option vests in 12 substantially equal monthly installments over one year starting June 17, 2026; any remaining unvested portion will vest the day before the next annual shareholders’ meeting, subject to continued service.
  • Transaction code: A (award/grant); no immediate exercise or sale reported.

Context

  • This was an option award to a director, not an open-market purchase or sale. Awards are common for executives and directors as compensation; they do not by themselves indicate an immediate buy or sell signal. The filing does not show exercise or sale of the underlying shares.

Insider Transaction Report

Form 4
Period: 2026-06-17
Transactions
  • Award

    Share Option (Right to Buy)

    [F1]
    2026-06-17+51,00051,000 total
    Exercise: $3.62Exp: 2036-06-17Class A Ordinary Shares (51,000 underlying)
Footnotes (1)
  • [F1]This option vests in twelve substantially equal monthly installments over a one-year period measured from June 17, 2026; provided, that any remaining unvested portion of the option award will vest as of the day immediately preceding the next annual meeting of shareholders following the grant date, subject to the Reporting Person's continued service as of each such vesting date.
Signature
/s/ Kim Davis, Attorney-in-Fact|2026-06-22

Documents

1 file
  • 4
    form4-06222026_040610.xmlPrimary